Shockwave S4: Addressing the Challenges of Calcified Below-the-Knee Disease

Dr. Melissa Loja shares her thoughts on IVL for the treatment of calcified infrapopliteal lesions and why she turns to Shockwave S4 for her most challenging cases.

DISRUPT BTK

By The Numbers

20
Patients from 3 sites
100%
Moderately/severely calcified lesions
75%
Rutherford Category V

Compelling Safety & Performance

in Severely Calcified Lesions*
95%
Procedural Success
0%
Perforations, Embolization, Slow/No Reflow, Abrupt Closure
26%
Final residual Stenosis with an acute gain of 1.5mm
0%
Major adverse event at 30 days
100%
Freedom From CD TLR at 30 days
*Core Lab & CEC adjudicated

Ready to Make Waves with Shockwave IVL?

ico email Connect
Disrupt

IT’S TIME TO

GET CRACKING

COUNTDOWN TO CAD III PRESENTATION

Days

Hours

Minutes

Seconds

TCT CONNECT

Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.
ISI: https://shockwavemedical.com/important-safety-information-coronary/